发明名称 Conjugated proteins
摘要 The present invention relates to modified therapeutic proteins, such as e.g. coagulation factors. In particular, the present invention relates to conjugated Factor VIII molecules such as e.g. FVII, FVIII, or FIX comprising a hydrophobic side group.
申请公布号 US9234192(B2) 申请公布日期 2016.01.12
申请号 US201113575207 申请日期 2011.02.09
申请人 Novo Nordisk A/S 发明人 Buchardt Jens;Behrens Carsten
分类号 A61K38/16;A61P29/00;A61P7/04;C12N9/64;A61K47/14;C07K14/745;C07K14/755 主分类号 A61K38/16
代理机构 代理人 Akopyan Nonna G.
主权项 1. A recombinant protein covalently conjugated to at least one hydrophobic side group having the formula: (A-W-B1-B2)z-asialoProtein wherein: asialoProtein represents a protein in which the terminal sialic acid has been removed from a glycan; z represents an integer of the value 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10; B2 represents a glycyl-sialic acid having the structure wherein R1, R1′, R2, R3, R4, R5, and R6 are either a bond connecting B2 with B1 or a hydrogen and * denotes the connection to asialoProtein; B1 represents a linker; W represents a chemical group linking A and B1; and A represents a hydrophobic albumin binding side group, wherein the side group is derived from substrate 1, 3 or 4; wherein substrate 1 is wherein substrate 3 isand wherein substrate 4 is
地址 Bagvaerd DK
您可能感兴趣的专利